Finance

Beta
Lists
300357:SHE
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
CN¥22.24
+1.09%
(+0.24) 1D
Jun 5, 3:04:40 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300357...
Open
CN¥22.26
High
CN¥22.74
Low
CN¥22.15
Mkt. cap
11.64B
Avg. vol.
8.93M
Volume
5.33M
P/E ratio
27.35
52-wk high
CN¥35.84
52-wk low
CN¥19.77
EPS
CN¥0.81
Shares outstanding
523.58M
No. of employees
2K
Open
CN¥22.26
High
CN¥22.74
Low
CN¥22.15
Mkt. cap
11.64B
Avg. vol.
8.93M
Volume
5.33M
P/E ratio
27.35
52-wk high
CN¥35.84
52-wk low
CN¥19.77
EPS
CN¥0.81
Shares outstanding
523.58M
No. of employees
2K
News stories
From sources across the web
About Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
CEO-
Employees1.81K
FoundedSep 19, 2002
Headquarters-
SectorPharmaceutical industry
Websitewolwobiotech.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
255.76M
369.12M
209.04M
252.84M
Cost of goods sold
11.75M
15.75M
11.11M
12.02M
Cost of revenue
11.75M
15.75M
11.11M
12.02M
Research and development expenses
29.19M
26.87M
31.40M
24.91M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
106.70M
134.52M
128.79M
117.09M
Operating expense
139.20M
166.35M
160.79M
143.93M
Total operating expenses
150.95M
182.11M
171.90M
155.95M
Operating income
104.82M
187.02M
37.15M
96.89M
Other non operating income
-210.56K
160.14K
-246.72K
-24.48K
EBT including unusual items
115.57M
194.75M
38.43M
131.78M
EBT excluding unusual items
111.55M
194.31M
41.38M
131.03M
Income tax expense
16.69M
29.94M
5.57M
15.27M
Effective tax rate
14.44%
15.37%
14.51%
11.59%
Other operating expenses
2.27M
972.53K
5.99M
-2.31M
Net income
102.67M
167.86M
36.07M
119.23M
Net profit margin
40.14%
45.47%
17.26%
47.16%
Earnings per share
-
-
-
-
Interest and investment income
7.13M
7.32M
4.67M
34.39M
Interest expense
-186.62K
-190.02K
-196.48K
-233.08K
Net interest expenses
6.95M
7.13M
4.48M
34.16M
Depreciation and amortization charges
-
-
-
-
EBITDA
116.23M
197.88M
49.60M
109.35M
Gain or loss from assets sale
-630.07K
630.07K
-630.07K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer